PRA-216 COPD Safety and Biomarker Study

NCT07730281 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: PRA-216
DRUG: Placebo

Sponsor

Prana Therapies Inc